Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest fibrosis Stories

2012-06-29 06:25:49

Foundation Gives Its Condolences and Heartfelt Gratitude to the Family of Dr. I.M. Rosenzweig and Will Name Research Award in His Honor CHICAGO, June 29, 2012 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation is deeply saddened to announce the recent death of one of its co-founders, I.M. Rosenzweig, PhD. Mike, as he was known to all, lost his courageous battle with idiopathic pulmonary fibrosis (IPF) on June 23, 2012. Mike, who was a clinical psychologist,...

2012-06-28 02:27:40

STOCKHOLM, June 28, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today reported that the Swedish Dental and Pharmaceutical Benefits Agency (TLV) has included Esbriet® (pirfenidone) on Sweden's list of reimbursed drugs, making Esbriet the first medicine for the treatment of idiopathic pulmonary fibrosis (IPF) to be reimbursed in Sweden. Magnus Skold, Professor and Consultant at the Lung and Allergy Clinic at Karolinska University Hospital, said, "Esbriet is a clear step forward....

2012-06-27 06:25:52

Legislation Passes Last Hurdle Before Going to President for Signature Bill Increases Patient and Expert Participation in FDA Review of Cystic Fibrosis and Other Rare Disease Drugs BETHESDA, Md., June 27, 2012 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation applauds passage of a bill in the United States Senate to expand cooperation between the Food and Drug Administration (FDA) and outside rare disease experts and patient advocates during the FDA drug approval process....

2012-06-20 14:21:09

Legislation Includes Measures to Increase Patient and Expert Participation in FDA Review of Rare Disease Medicines BETHESDA, Md., June 20, 2012 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation issued the following statement in response to passage of legislation today in the House of Representatives to expand consultation between the Food and Drug Administration (FDA) and external rare disease experts and patient advocates during the FDA drug approval process. The bill is...

2012-06-14 02:24:31

BRISBANE, Calif., June 14, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that Daniel G. Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Wells Fargo Securities 2012 Healthcare Conference in Boston on Tuesday, June 19 at 3:00 p.m. EDT. To access a live audio webcast of any of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at www.intermune.com....

2012-06-06 06:20:16

World-renowned Dirty Car Artist Scott Wade joins ninth annual Soaps It Up for Cystic Fibrosis Canada HAMILTON, ON, June 6, 2012 /CNW/ - For the past eight years, dirty cars have been making beautiful things happen for Cystic Fibrosis Canada through the annual CARSTAR Soaps It Up for Cystic Fibrosis National Car Wash Fundraiser. At this year's event on Saturday, June 9th, CARSTAR locations across the country will surpass $2-million in funds raised for Cystic Fibrosis Canada.  To...

2012-05-31 11:39:24

Researchers at the University of Pittsburgh School of Medicine have identified an agent that in lab tests protected the skin and lungs from fibrosis, a process that can ultimately end in organ failure and even death because the damaged tissue becomes scarred and can no longer function properly. The findings were published today in Science Translational Medicine. There are no effective therapies for life-threatening illnesses such as idiopathic pulmonary fibrosis and systemic sclerosis,...

2012-05-24 14:21:49

Canadian Double-Lung Transplant Recipient Receives Diamond Jubilee Medal from Canadian Prime Minister Harper CHICAGO, May 24, 2012 /PRNewswire-USNewswire/ -- In her first public appearance since her surgery, 21-year-old, double-lung transplant recipient Helene Campbell held a press conference today about her journey and work promoting organ donation. Yesterday the Canadian Prime Minister Stephen Harper awarded Ms. Campbell with the Diamond Jubilee Medal for her work raising awareness...

2012-05-14 10:25:07

Foundation Announces Suite of Complementary Initiatives for Patients and Caregivers to Provide Enhanced Resources and Support CHICAGO, May 14, 2012 /PRNewswire-USNewswire/ -- With no FDA-approved treatment or cure for pulmonary fibrosis (PF), support groups are an important aspect to providing patients and families with a forum to improve their lives while living with the disease. Providing accessibility and improving opportunities for individuals to build their network of support,...

2012-05-10 06:27:13

ATLANTA, May 10, 2012 /PRNewswire/ -- The Cystic Fibrosis Foundation - Georgia Chapter will hold its 22(nd) Annual GREAT STRIDES walk. The event will be held on Saturday, May 19th at the IC Courtyard on the Georgia Tech campus; registration begins at 8:30 a.m., and the 5K walk begins at 9:30 a.m. Great Strides is a national fundraising program that aims to raise $40 million in 2012 to support vital cystic fibrosis research, education and care programs. It is the CF...